Companies House · 02723534

ASTRAZENECA PLC

UK registered company, public limited company, incorporated 17 Jun 1992.

Active
40
Public contracts
0
Spend payments
Total spend

ASTRAZENECA PLC is a UK company registered at Companies House under number 02723534. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
02723534
Status
Active
Company type
Public Limited Company
Incorporated
17 Jun 1992
Country of origin
United Kingdom
Registered office
1 FRANCIS CRICK AVENUE, CAMBRIDGE, CB2 0AA, UNITED KINGDOM
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products; 21200 - Manufacture of pharmaceutical preparations
Accounts category
GROUP
View source on data.gov.uk

Public sector contracts

Contract awards linked to ASTRAZENECA PLC.

ProcurementBuyerAwardedValue
NHS Framework Agreement for Branded Medicines - National TenderNHS England
Medicinal Products Dynamic Purchasing System (131864)Regional Business Services Organisation, Procurement and Logistics Service
NHS Branded Medicines Framework for North of England and Midlands and East of England - 1 March 2024NHS England
NHS Branded Medicines Framework for North of England and Midlands and East of England - 1 March 2024NHS England
NHS National Proprietary Category Tender - 1 May 2024NHS England
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS England
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
Contract for the supply of live attenuated intranasal influenza vaccineDepartment of Health and Social Care
Contract for the supply of live attenuated intranasal influenza vaccineDepartment of Health and Social Care
Invitation to offer for NHS London Branded Medicines - Tranche A and AnnualNHS England
NHS South of England Branded Medicines - Tranche B and AnnualNHS England
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework, North of England, Branded Medicines - Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS National Pharmaceuticals — Fulvestrant, Darunavir and ImatinibThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza NationalNHS England24 Jun 2025£261.9m
NHS Branded Medicines Tranche Framework for London and South of EnglandNHS England21 Jul 2024£381m
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS England4 Apr 2024£1bn
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024NHS England26 Jan 2024£688m
NHS South of England Branded Medicines - Tranche A - September 2023NHS England17 Jul 2023£249.8m
NHS London Branded Medicines - Tranche B - September 2023NHS England13 Jul 2023£231.1m
NHS Midland & East Branded Medicines, Tranche B & Annual TrancheNHS England13 Feb 2023£480.4m
NHS Framework for North of England Branded Medicines Tranche A & Annual TrancheNHS England8 Feb 2023£262m
NHS Framework Agreement for South of England Branded - Tranche B and AnnualNHS England14 Jul 2022£338.7m
NHS Framework Agreement for London, Branded Medicines - Tranche A and AnnualNHS England14 Jul 2022£153.8m
NHS Framework Agreement for Branded medicines - NationalNHS England15 May 2022£526m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for Midlands and East, Branded Medicines - Tranche A and AnnualNHS England7 Feb 2022£216.1m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
Contract for the supply of live attenuated intranasal influenza vaccineDepartment of Health and Social Care (DHSC)20 Mar 2021£1
NHS Framework for the Midlands and East, Branded Medicines - Tranche BNHS England25 Jan 2021£228.2m
NHS National Pharmaceuticals - Fulvestrant, Darunavir and ImatinibNHS England4 Jan 2021£17.3m
Provision of Services to Support the UK Covid-19 Testing StrategyDepartment of Health and Social Care26 Apr 2020£152m

Supplier identities

How this company appears as a supplier across the data.

FAQs about ASTRAZENECA PLC

Is ASTRAZENECA PLC an active company?

ASTRAZENECA PLC (company number 02723534) is recorded as "Active", incorporated on 17 Jun 1992.

What does ASTRAZENECA PLC do?

Its Companies House nature-of-business (SIC) is: 21100 - Manufacture of basic pharmaceutical products; 21200 - Manufacture of pharmaceutical preparations.

Has ASTRAZENECA PLC won UK public-sector contracts?

Yes — 40 public-sector contract awards are linked to this company in our data.

Where is ASTRAZENECA PLC based?

Its registered office is 1 FRANCIS CRICK AVENUE, CAMBRIDGE, CB2 0AA, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable